Related Experiment Video
Updated: Jul 19, 2025

07:59
Murine Full-thickness Skin Transplantation
Published on: January 2, 2017
20.3K
Novel Approaches to Immunomodulation for Solid Organ Transplantation
Irma Husain1, Xunrong Luo1,2
1Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA;
Annual Review of Medicine
|August 10, 2023
Summary
Current transplantation immunomodulation is limited, stalling long-term graft survival. Novel therapies beyond adaptive immunity could improve graft repair, tolerance, and longevity by personalizing donor and recipient treatments.
Area of Science:
- Immunology
- Transplantation Science
- Regenerative Medicine
Background:
- Despite advances, current immunosuppression limits long-term graft survival in transplantation.
- Calcineurin inhibitors improve short-term outcomes but have plateaued long-term efficacy.
- Limited therapeutic options exist for effective immunomodulation in organ transplantation.
Purpose of the Study:
- To review current limitations in transplantation immunomodulation.
- To explore novel therapeutic strategies beyond adaptive immunity.
- To discuss personalized approaches for optimizing graft survival and tolerance.
Main Methods:
- Review of recent literature on transplantation and immunomodulation.
- Analysis of emerging therapies targeting ischemic injury and aging.
- Discussion of strategies for donor pool expansion and xenotransplantation.
- Emphasis on individualized treatment based on donor and recipient factors.
Main Results:
- Current immunosuppression strategies have reached a plateau in improving long-term graft survival.
- Therapies targeting ischemia, aging, and repair offer potential beyond adaptive immunity.
- Donor pool expansion and bioengineering present new avenues for organ availability.
- Personalized medicine approaches are crucial for maximizing therapeutic impact.
Conclusions:
- Novel immunomodulatory strategies are needed to overcome the limitations of current therapies.
- Holistic approaches addressing graft injury, aging, and tolerance are promising.
- Individualized treatment plans are essential for advancing long-term organ transplant success.
Related Concept Videos
Cell-mediated Immune Responses
68.9K
Overview
68.9K
Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
Tissue Transplantation
396
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
396
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Cytotoxic T Cells-mediated Immune Response
971
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
971

